Northern Trust Corp Cuts Holdings in Grifols, S.A. (NASDAQ:GRFS)

09:18am, Saturday, 27'th Nov 2021 Dakota Financial News
Northern Trust Corp lowered its stake in shares of Grifols, S.A. (NASDAQ:GRFS) by 26.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 108,233 shares of the biotechnology companys stock after selling 38,014 shares during the period. Northern Trust Corps holdings in Grifols were worth $1,878,000 []
Parametric Portfolio Associates LLC grew its position in shares of Grifols, S.A. (NASDAQ:GRFS) by 18.7% during the second quarter, according to its most recent filing with the SEC. The firm owned 879,324 shares of the biotechnology company’s stock after acquiring an additional 138,540 shares during the period. Parametric Portfolio Associates LLC owned about 0.13% of […]
The global Human Rabies Immunoglobulin (IM) market was valued at 27.93 Million USD in 2020 and will grow with a CAGR of 7.34% from 2021 to 2027. According to a research report performed by Infinity Business Insights analysts, the Human
Lapides Asset Management LLC boosted its holdings in shares of Grifols, S.A. (NASDAQ:GRFS) by 83.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 492,600 shares of the biotechnology companys stock after purchasing an additional 224,200 shares during the period. Grifols accounts for []
Overview Disposable Blood Bags are marketed under government contracts and appropriations through the tendering procedure at public hospitals and federal blood banks. Disposable Blood Bags are also in high demand among privately financed hospitals, clinics, and blood banks. Throughout blood donation
According to the new report released, the global intravenous solution market was valued at US$ 8,372.0 million in 2019 and is expected to grow at a CAGR of 6.1 % during the forecast period of 2019-2027. Increasing prevalence of kidney
The biopharma industry has high ambitions to improve therapies for patients across many disease categories, drawing on a wealth of technological advances that have been emerging and maturing in recent years. Even after the mass mobilization against COVID-19, it is

Grifols (NASDAQ:GRFS) Shares Gap Down to $12.55

10:04am, Saturday, 20'th Nov 2021 Dakota Financial News
Grifols, S.A. (NASDAQ:GRFS)s share price gapped down before the market opened on Thursday . The stock had previously closed at $12.55, but opened at $12.10. Grifols shares last traded at $12.01, with a volume of 8,198 shares traded. A number of brokerages have issued reports on GRFS. Barclays cut Grifols from an overweight rating to []
To provide a precise market overview, this Immunoglobulin market report is divided into several distinct and important market segments and applications. Through this comprehensive Market research study in this Immunoglobulin market report, industries will learn about the vast opportunities available
The Corner Renta 4 | Grifols (GRF) and GIC have obtained the relevant regulatory authorisations to allow The Sovereign Wealth Fund of Singapore to go ahead with its investment to buy 23.8% of Biomat for 990 million dollars. Grifols will, of course, still maintain operating control of the company, as well as access to the recovered plasma in the over 300 plasma donation centres Biomat has in the United States. The funds
Transparency Market Research (TMR) has published a new report titled, Subcutaneous Immunoglobulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20192027. According to the report, the global subcutaneous immunoglobulin market was valued at US$ 4.0 Mn in

New Strong Sell Stocks for September 22nd

12:16pm, Wednesday, 22'nd Sep 2021
MANU, GRFS, IMCC, and INTZ have been added to the Zacks Rank #5 (Strong Sell) List on September 22, 2021
Spanish pharmaceutical company Grifols SA said Friday that it has reached an agreement to acquire a majority stake in German peer Biotest AG.

Grifols Sells Off With Effects of Pandemic

03:11pm, Monday, 23'rd Aug 2021
Spain-based biotech Grifols SA ( GRFS , Financial) is trading low due to the effects of the pandemic on sales and revenue. The company is completely vertically integrated in the plasma business.

Moving Average Crossover Alert: Grifols (GRFS)

07:45am, Wednesday, 14'th Jul 2021
Grifols (GRFS) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE